Boujenah J, Cedrin-Durnerin I, Herbemont C, Bricou A, Sifer C, Poncelet C
Department of Obstetrics, Gynaecology and Assisted Reproductive Technologies Centre, Hôpitaux Universitaires Paris Seine Saint-Denis, Assistance Publique-Hôpitaux de Paris, Bondy, France; Université Paris 13, Sorbonne Paris Cité, Bobigny, France.
Department of Obstetrics, Gynaecology and Assisted Reproductive Technologies Centre, Hôpitaux Universitaires Paris Seine Saint-Denis, Assistance Publique-Hôpitaux de Paris, Bondy, France.
Eur J Obstet Gynecol Reprod Biol. 2017 Dec;219:28-34. doi: 10.1016/j.ejogrb.2017.10.001. Epub 2017 Oct 10.
To perform a prospective evaluation of postoperative fertility management using the endometriosis fertility index (EFI).
This prospective non-interventional observational study was performed from January 2013 to February 2016 in a tertiary care university hospital and an assisted reproductive technology (ART) centre. In total, 196 patients underwent laparoscopic surgery for endometriosis-related infertility. Indications for surgery included pelvic pain (dysmenorrhoea, and/or deep dyspareunia), abnormal hysterosalpingogram, and failure to conceive after three or more superovulation cycles with or without intra-uterine insemination. Multidisciplinary fertility management followed the surgical diagnosis and treatment of endometriosis. Three postoperative options were proposed to couples based on the EFI score: EFI score ≤4, ART (Option 1); EFI score 5-6, non-ART management for 4-6 months followed by ART (Option 2); or EFI score ≥7, non-ART management for 6-9 months followed by ART (Option 3). The main outcomes were non-ART pregnancy rates and cumulative pregnancy rates according to EFI score. Univariate and multivariate analyses with backward stepwise logistic regression were used to explain the occurrence of non-ART pregnancy after surgery for women with EFI scores ≥5. Adjustment was made for potential confounding variables that were significant (p<0.05) or tending towards significance (p<0.1) on univariate analysis.
The cumulative pregnancy rate was 76%. The total number of women and pregnancy rates for Options 1, 2 and 3 were: 26 and 42.3%; 56 and 67.9%; and 114 and 87.7%, respectively. The non-ART pregnancy rates for Options 1, 2 and 3 were 0%, 30.5% and 48.2%, respectively. The ART pregnancy rates for Options 1, 2 and 3 were 50%, 60.6% and 80.3%, respectively. The mean time to conceive for non-ART pregnancies was 4.2 months. The benefit of ART was inversely correlated with the mean EFI score. On multivariate analysis, the EFI score was significantly associated with non-ART pregnancy (odds ratio 1.629, 95% confidence interval 1.235-2.150).
In daily prospective practice, the EFI was useful for subsequent postoperative fertility management in infertile patients with endometriosis.
使用子宫内膜异位症生育指数(EFI)对术后生育管理进行前瞻性评估。
这项前瞻性非干预性观察性研究于2013年1月至2016年2月在一家三级护理大学医院和一个辅助生殖技术(ART)中心进行。共有196例因子宫内膜异位症相关不孕接受腹腔镜手术的患者。手术指征包括盆腔疼痛(痛经和/或深部性交困难)、子宫输卵管造影异常,以及在进行三个或更多超排卵周期(无论有无宫内人工授精)后仍未受孕。多学科生育管理遵循子宫内膜异位症的手术诊断和治疗。根据EFI评分向夫妇提出三种术后选择:EFI评分≤4,进行辅助生殖技术(方案1);EFI评分5 - 6,进行4 - 6个月的非辅助生殖技术管理,随后进行辅助生殖技术(方案2);或EFI评分≥7,进行6 - 9个月的非辅助生殖技术管理,随后进行辅助生殖技术(方案3)。主要结局是根据EFI评分的非辅助生殖技术妊娠率和累积妊娠率。对EFI评分≥5的女性术后非辅助生殖技术妊娠的发生情况进行单因素和多因素分析,并采用向后逐步逻辑回归。对单因素分析中具有显著性(p<0.05)或趋于显著性(p<0.1)的潜在混杂变量进行了校正。
累积妊娠率为76%。方案1、2和3的女性总数及妊娠率分别为:26例和42.3%;56例和67.9%;114例和87.7%。方案1、2和3的非辅助生殖技术妊娠率分别为0%、30.5%和48.2%。方案1、2和3的辅助生殖技术妊娠率分别为50%、60.6%和80.3%。非辅助生殖技术妊娠的平均受孕时间为4.2个月。辅助生殖技术的益处与平均EFI评分呈负相关。多因素分析显示,EFI评分与非辅助生殖技术妊娠显著相关(优势比1.629,95%置信区间1.235 - 2.150)。
在日常前瞻性实践中,EFI对子宫内膜异位症不孕患者术后的后续生育管理有用。